ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression

2001 ◽  
Vol 94 (6) ◽  
pp. 774-782 ◽  
Author(s):  
Neil G. Anderson ◽  
Tawhid Ahmad ◽  
Kai Chan ◽  
Richard Dobson ◽  
Nigel J. Bundred
Sign in / Sign up

Export Citation Format

Share Document